Treatment of Osteoarthritis With the Stromal Vascular Fraction of Abdominal Adipose Tissue - a Pilot Study
Launched by HVIDOVRE UNIVERSITY HOSPITAL · Mar 2, 2016
Trial Information
Current as of May 27, 2025
Completed
Keywords
ClinConnect Summary
Background Osteoarthritis (OA) of the knee is a destructive joint disease, causing degeneration of cartilage, damage to the underlying bone and morphological changes to the joint1. It is a major public health concern due to the increased life expectancy of the ageing population2,3. No approved medical treatment that reverses the morphological changes currently exists. Conventional treatment includes physiotherapy, pain killers, braces and in end-stage OA surgical knee replacement4.
Treatment of Osteoarthritis with Paqe 3 Version 2 the Stromal Vascular Fraction of Adipose tissue 02-11-2015 ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18-70 years. Kellgren-Lawrence grade 1 - 4 evaluated on x-ray or ICRS grade 2-4 evaluated on MRI.
- • The patient must be expected to be able to attend rehabilitation and post-examinations.
- • The patient must be able to speak and understand Danish. The patient must be able to give informed consent.
- Exclusion Criteria:
- • Varus or valgus malalignment of the knee \> 5 degrees. BMI \> 35 Terminal illness or severe medical illness: ASA score higher than or equal to 3.
About Hvidovre University Hospital
Hvidovre University Hospital is a leading clinical research institution located in Denmark, dedicated to advancing medical science through rigorous clinical trials and innovative healthcare solutions. As a prominent academic hospital, it integrates patient care with research, fostering collaboration among multidisciplinary teams of healthcare professionals, researchers, and academic institutions. Hvidovre University Hospital is committed to enhancing patient outcomes by conducting high-quality clinical studies across various therapeutic areas, ensuring adherence to ethical standards and regulatory compliance. Its state-of-the-art facilities and focus on translational medicine position the hospital as a key player in the development of new treatments and therapies, ultimately contributing to the improvement of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Koege, , Denmark
Patients applied
Trial Officials
Kristoffer Barfod
Principal Investigator
Copenhagen University Hospital, Hvidovre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials